NextCell Sverige AB
559496-7282ActiveDeveloping revolutionary stem cell therapies for autoimmune diseases.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2024
- Grundat
Nyckelbeslutsfattare
Mathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Lindsay Davies
CSO / CEO of QVance
Mathias Svahn
CEO
+9 fler kontakter i Funnelfeedr
Beskrivning
NextCell Pharma is a Swedish biotechnology company focused on revolutionizing treatments for severe and incurable diseases using stem cell therapies. The company operates three main business areas: ProTrans, Cellaviva, and QVance, all centered around advanced therapy medicinal products (ATMPs). Thei...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559496728201
Beslutsfattare
13 kontakter i FunnelfeedrMathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Lindsay Davies
CSO / CEO of QVance
Mathias Svahn
CEO
Camilla Myhre Sandberg
Board Member
Hans-Peter Ekre
Chairman of the Board
Sofie Falk Jansson
CEO of Cellaviva
Eva Sjökvist Saers
Board Member
Sofia Sisay
Head of Clinical Trials
Edvard Smith
Medical Director
Övriga kontakter
Per-Ola Carlsson
Advisor
Eric Strati
Advisor
Angela Vollstedt
Advisor
Liknande företag
20 liknande företag i FunnelfeedrCellaviva AB
5–9 anställdaScandinavia's largest private bank storing family stem cells for future health.
QVance AB
1–4 anställdaSpecialist quality control analytics provider for cell and gene therapies.
CELLINK Bioprinting AB
20–49 anställdaLeading provider of advanced 3D bioprinting systems and biomaterials.
Fluicell AB
10–19 anställdaDeveloping precision-engineered tissues using single-cell bioprinting technology.
Xintela AB
10–19 anställdaDeveloping stem cell and targeted cancer therapies for unmet needs.
Frågor om NextCell Sverige AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo